Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates

Metagenomi (MGX) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of$ 0.62. This compares to loss of $1.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.68%. A quarter ago, it was expected that this genetic medicines company would post a loss of$ 0.62 per share when it actually produced a loss of $0.63, delivering a surprise of -1.61%.Over the last four quarters, the company ...